AI-assisted Colorectal Cancer Diagnosis System

About it

The Colorectal Biopsy AI-Assisted Diagnostic System automatically detects and grades colorectal cancer and adenomatous lesions.

It distinguishes adenocarcinoma, adenoma subtypes, and benign polyps, addressing missed serrated lesions and grading challenges.

By reducing analysis time and bias, it enhances diagnostic accuracy and supports adenoma–carcinoma risk assessment.

Accurate Lesion Detection

Optimized to detect high-risk serrated adenomas often missed in routine diagnosis.

Adenoma Subtype Classification

Automatically identifies tubular, villous, and tubulovillous adenomas and quantifies villous components for risk assessment.

Automated Grading & Segmentation

Visually segments lesions and grades low- vs. high-grade intraepithelial neoplasia.

Structured Report Output

Generates reports with adenoma subtype, grade, and heatmap visualization, ready for LIS/PIS integration.

Extensive Training Dataset

Trained on 20,000+ slides covering all colorectal regions and adenoma–carcinoma progression stages.

Proven Clinical Accuracy

Achieves 99% sensitivity and 95% specificity in multi-center validations.

Recognizable Lesion Types
Primary Category Secondary Attribute
Positive Cancer Adenocarcinoma / Signet Ring Cell Carcinoma / Mucinous Adenocarcinoma / Other Cancers (Developing)
High-grade Intraepithelial Neoplasia Serrated Lesion / Tubular Adenoma / Villous Adenoma / Tubulovillous Adenoma
Low-grade Intraepithelial Neoplasia Serrated Lesion / Tubular Adenoma / Villous Adenoma / Tubulovillous Adenoma
Glandular Lesion Changes (Developing)
Negative Acute Inflammation Mild / Moderate / Severe
Chronic Inflammation
Serrated Lesion without Dysplasia
Hyperplastic Polyp

Powering global digital pathology with performance, scale, and trust

The Numbers Behind Our Innovation

0%
99% Sensitivity Ensures accurate detection of colorectal neoplastic lesions across multiple centers.
0+
20000+ Slides ,Comprehensive dataset covering sigmoid colon, rectum, and other anatomical regions.
0%
95% Specificity,Minimizes false positives while maintaining diagnostic precision.
0%
97.2% Accuracy,Confirmed by large-scale validation at Adicon Laboratories and tertiary hospitals.
0%
96.72% Low-Grade Detection Rate , Validated in clinical trials at Wuhan Union Hospital.
0%
89.47% NPV ,Ensures reliable exclusion of negative cases for efficient screening.

Network and GPU Server Requirements